跳至主要内容
临床试验/NCT04296357
NCT04296357已完成不适用

Follow-up of Children Born From In-vitro Maturation Versus In-vitro Fertilization: Follow-up of a Randomized Controlled Trial

Mỹ Đức Hospital1 个研究点 分布在 1 个国家目标入组 231 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
231
试验地点
1
主要终点
The average total ASQ-3 score

研究概览

简要总结

The investigators conduct a follow up of our randomized controlled trial (RCT) to investigate the development of children born from In-vitro fertilization (IVF) and In-vitro maturation (IVM), in order to give strong evidence about the safety of IVM in women with high antral follicle count or especially polycystic ovary syndrome (PCOS).

详细描述

Since the birth of the first baby born from in-vitro maturation (IVM) in 1991, this technique has been considered an alternative solution for treating infertility beside conventional controlled ovarian stimulation for in-vitro fertilization (IVF). Since then, there are already more than 5000 children born from IVM, and that number is on the trend of increasing.

Regarding technique, immature oocytes (germinal vesicle - GV) were aspirated from secondary follicles sized from 2-10mm, under follicle-stimulating hormone (FSH) priming or no ovarian stimulation at all. Afterward, the maturation process was undertaken in an artificial medium, out of a living body. This technique, by reducing the usage of external hormones, is highly effective in minimizing the risk of ovarian hyperstimulation syndrome (OHSS) in women with high antral follicle count, especially polycystic ovarian syndrome, with a rate of OHSS recorded as low as 0 percent. Alongside that, the pregnancy rate, as well as the live birth rate of IVM, when proceeded well, is not lower than conventional IVF. Until now, there is only one randomized controlled trial comparing these two techniques directly.

Due to differences in the process of culturing between IVM and IVF, primarily the maturation is undertaken in an artificial medium, the health of children born from IVM received many interests. Numerous studies have been conducted to compare the development of children born from IVM and IVF. Neonatal outcomes of children born from IVM and IVF are considerably comparable. And the development of children born from these two techniques is not significantly different. All the information, as mentioned above, was not from randomized controlled trials but retrospective or prospective cohort studies. Thus, we conduct a follow up of our RCT to investigate the development of children born from IVM and IVM, to give strong evidence about the safety of IVM in women with high antral follicle count or especially PCOS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Months 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • All live babies born following the In-vitro Maturation and In-vitro fertilization from our FM study.
  • Parents agree to participate in the study.

排除标准

  • Babies died under or at 24 months

结局指标

主要结局

The average total ASQ-3 score

时间窗: Up to 24 months after birth

ASQ-3 (Ages and Stages Questionaires®) has 5 aspects: Communication, Gross motor, Fine motor, Problem solving and Personal-Social Each aspect has 6 questions, if the answer is Yes, score = 10, Sometimes = 5 and Not yet = 0. ASQ-3 average = average score of 5 aspects.

次要结局

  • Height(Up to 24 months after birth)
  • Duration of breast-feeding(Up to 24 months after birth)
  • Name of diseases that lead to hospital admission(Up to 24 months after birth)
  • Score of Problem solving(Up to 24 months after birth)
  • Number of hospital admission(Up to 24 months after birth)
  • Score of Gross motor(Up to 24 months after birth)
  • Score of Fine motor(Up to 24 months after birth)
  • Score of Communication(Up to 24 months after birth)
  • Score of Personal-Social(Up to 24 months after birth)
  • The rate of children who have at least one red flag sign(From 6 months to 24 months after birth)
  • Infant age at which weaning starts(Up to 24 months after birth)
  • Weight(Up to 24 months after birth)

研究者

发起方
Mỹ Đức Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验